An analysis of tissue samples from the autopsies of 44 people who died with COVID-19 shows that SAR-CoV-2 virus spread throughout the body—including into the brain—and that it lingered for almost eight months. The study ...
Dec 30, 2022
0
380
Children exhale significantly fewer potentially infectious particles than adults—at least this is true for the small respiratory droplets that are predominantly produced in the lungs. This is a key finding of a study conducted ...
Dec 22, 2022
0
52
Researchers are investigating whether the COVID virus can affect vision and depth-perception of those infected.
Dec 21, 2022
0
85
The world's largest trial into the effect of multiple interventions for critically ill adults with COVID-19 on longer-term outcomes has released results from the 180-day (six month) follow-up of 4,869 critically ill patients.
Dec 19, 2022
0
42
Following established guidelines about prescription drugs would seem to be an obvious course of action, especially for the professionals that do the prescribing. Yet doctors and their family members are less likely than other ...
Dec 16, 2022
0
300
The Pfizer-BioNTech and Moderna mRNA vaccines have played a large role in preventing deaths and severe infections from COVID-19. But researchers are still in the process of developing alternative approaches to vaccines to ...
Dec 15, 2022
0
9
Like Canadian Prime Minister Justin Trudeau and Mexican President Andrés Obrador before him, Prime Minister Anthony Albanese has been infected with COVID for a second time.
Dec 9, 2022
0
24
Cases of respiratory syncytial virus (RSV) are usually at their worst during the winter months. This year, however, has seen a marked increase of cases in the summer, leading to overcrowding in hospitals throughout the United ...
Dec 1, 2022
0
4
A study conducted in Brazil and reported in an article in Vaccines shows that in the São José do Rio Preto region in the northwest of São Paulo state, only 75.8% of children aged 0-15 have antibodies against measles. The ...
Dec 1, 2022
0
9
Researchers from the Centenary Institute and the University of Sydney have developed a new nasal vaccination strategy that induces potent lung immunity and protection against the SARS-CoV-2 coronavirus.
Nov 16, 2022
0
92
